This regulation could be achieved through a direct interaction of USP9X with the transcription factor ETS-1, preventing its proteasomal degradation by deubiquitination, and favoring its binding activity on NRAS promoters in melanoma cells [53]. This evidence concerns the gene ETS1 and melanoma.